Pan-cancer analysis of PIEZO1: a promising biomarker for diagnosis, prognosis, and targeted therapies Article Swipe
Qian Wang
,
Yu Yan
,
Liang Xiao
,
Dan Wan
,
Ke Du
,
Pengpeng Zhu
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.3389/fimmu.2025.1625734
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.3389/fimmu.2025.1625734
Introduction Piezo-type mechanosensitive channel component 1 (PIEZO1), a mechanically gated cation channel involved in calcium signaling, has been recognized as a potential oncogene in some cancers. However, its comprehensive pan-cancer role remains unexplored. Methods This study used The Cancer Genome Atlas (TCGA) data to analyze PIEZO1 expression profiles. Diagnostic value was evaluated using Receiver Operating Characteristic (ROC) curve analysis, with primary tumor samples as cases and adjacent normal tissues as controls. Prognostic value was determined through Cox regression and Kaplan-Meier survival analyses. Clinical correlations were detected using non-parametric tests and logistic regression. Genomic alterations were identified via the cBioPortal database. Functional pathways were analyzed using the R language. The association between PIEZO1 and tumor microenvironment scores (Stromal, Immune, ESTIMATE) or immune checkpoint markers (CD274, CTLA4, LAG3, PDCD1, PDCD1LG2) were analyzed using the R language. Quantitative Real-Time PCR (qRT-PCR) and Western Blotting (WB) were performed to quantify PIEZO1 expression in clinical specimens. Colony formation and wound healing assays assessed PIEZO1’s in vitro effects on cancer cells, while xenograft models evaluated its in vivo impact on tumor growth. Results Our analysis revealed that PIEZO1 has diagnostic and prognostic value across different cancer types. Elevated PIEZO1 expression was associated with advanced tumor grade and stage. Genomic alterations in PIEZO1 were found in 4% of pan-cancer patients. Functional enrichment analyses revealed that PIEZO1-coexpressed genes were significantly enriched in ECM-receptor signaling, cell migration, and ion homeostasis. PIEZO1 positively correlated with tumor microenvironment scores and immune checkpoints. Experimental validation confirmed PIEZO1 overexpression in LIHC and its pro-tumorigenic role in vitro / in vivo . Conclusion Our findings indicate that PIEZO1 is a promising marker for the diagnosis, prognosis, and development of targeted pan-cancer therapies.
Related Topics
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.3389/fimmu.2025.1625734
- https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1625734/pdf
- OA Status
- gold
- References
- 54
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4413998857
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4413998857Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3389/fimmu.2025.1625734Digital Object Identifier
- Title
-
Pan-cancer analysis of PIEZO1: a promising biomarker for diagnosis, prognosis, and targeted therapiesWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-09-04Full publication date if available
- Authors
-
Qian Wang, Yu Yan, Liang Xiao, Dan Wan, Ke Du, Pengpeng ZhuList of authors in order
- Landing page
-
https://doi.org/10.3389/fimmu.2025.1625734Publisher landing page
- PDF URL
-
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1625734/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1625734/pdfDirect OA link when available
- Concepts
-
Biomarker, Medicine, Cancer, Targeted therapy, Internal medicine, Biology, BiochemistryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
54Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4413998857 |
|---|---|
| doi | https://doi.org/10.3389/fimmu.2025.1625734 |
| ids.doi | https://doi.org/10.3389/fimmu.2025.1625734 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40977743 |
| ids.openalex | https://openalex.org/W4413998857 |
| fwci | 0.0 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000235 |
| mesh[1].descriptor_ui | D007473 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | genetics |
| mesh[1].descriptor_name | Ion Channels |
| mesh[2].qualifier_ui | Q000378 |
| mesh[2].descriptor_ui | D007473 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | metabolism |
| mesh[2].descriptor_name | Ion Channels |
| mesh[3].qualifier_ui | Q000235 |
| mesh[3].descriptor_ui | D014408 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | genetics |
| mesh[3].descriptor_name | Biomarkers, Tumor |
| mesh[4].qualifier_ui | Q000378 |
| mesh[4].descriptor_ui | D014408 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | metabolism |
| mesh[4].descriptor_name | Biomarkers, Tumor |
| mesh[5].qualifier_ui | Q000175 |
| mesh[5].descriptor_ui | D009369 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | diagnosis |
| mesh[5].descriptor_name | Neoplasms |
| mesh[6].qualifier_ui | Q000235 |
| mesh[6].descriptor_ui | D009369 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | genetics |
| mesh[6].descriptor_name | Neoplasms |
| mesh[7].qualifier_ui | Q000378 |
| mesh[7].descriptor_ui | D009369 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | metabolism |
| mesh[7].descriptor_name | Neoplasms |
| mesh[8].qualifier_ui | Q000401 |
| mesh[8].descriptor_ui | D009369 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | mortality |
| mesh[8].descriptor_name | Neoplasms |
| mesh[9].qualifier_ui | Q000628 |
| mesh[9].descriptor_ui | D009369 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | therapy |
| mesh[9].descriptor_name | Neoplasms |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D011379 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Prognosis |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D000818 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Animals |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D059016 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Tumor Microenvironment |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D051379 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Mice |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D005260 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Female |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D045744 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Cell Line, Tumor |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D008297 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Male |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D015972 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Gene Expression Regulation, Neoplastic |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D058990 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Molecular Targeted Therapy |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D023041 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Xenograft Model Antitumor Assays |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D006801 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Humans |
| mesh[21].qualifier_ui | Q000235 |
| mesh[21].descriptor_ui | D007473 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | genetics |
| mesh[21].descriptor_name | Ion Channels |
| mesh[22].qualifier_ui | Q000378 |
| mesh[22].descriptor_ui | D007473 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | metabolism |
| mesh[22].descriptor_name | Ion Channels |
| mesh[23].qualifier_ui | Q000235 |
| mesh[23].descriptor_ui | D014408 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | genetics |
| mesh[23].descriptor_name | Biomarkers, Tumor |
| mesh[24].qualifier_ui | Q000378 |
| mesh[24].descriptor_ui | D014408 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | metabolism |
| mesh[24].descriptor_name | Biomarkers, Tumor |
| mesh[25].qualifier_ui | Q000175 |
| mesh[25].descriptor_ui | D009369 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | diagnosis |
| mesh[25].descriptor_name | Neoplasms |
| mesh[26].qualifier_ui | Q000235 |
| mesh[26].descriptor_ui | D009369 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | genetics |
| mesh[26].descriptor_name | Neoplasms |
| mesh[27].qualifier_ui | Q000378 |
| mesh[27].descriptor_ui | D009369 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | metabolism |
| mesh[27].descriptor_name | Neoplasms |
| mesh[28].qualifier_ui | Q000401 |
| mesh[28].descriptor_ui | D009369 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | mortality |
| mesh[28].descriptor_name | Neoplasms |
| mesh[29].qualifier_ui | Q000628 |
| mesh[29].descriptor_ui | D009369 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | therapy |
| mesh[29].descriptor_name | Neoplasms |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D011379 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Prognosis |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D000818 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Animals |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D059016 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Tumor Microenvironment |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D051379 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Mice |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D005260 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Female |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D045744 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Cell Line, Tumor |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D008297 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Male |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D015972 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Gene Expression Regulation, Neoplastic |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D058990 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Molecular Targeted Therapy |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D023041 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Xenograft Model Antitumor Assays |
| type | article |
| title | Pan-cancer analysis of PIEZO1: a promising biomarker for diagnosis, prognosis, and targeted therapies |
| biblio.issue | |
| biblio.volume | 16 |
| biblio.last_page | 1625734 |
| biblio.first_page | 1625734 |
| topics[0].id | https://openalex.org/T12286 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9995999932289124 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2737 |
| topics[0].subfield.display_name | Physiology |
| topics[0].display_name | Erythrocyte Function and Pathophysiology |
| topics[1].id | https://openalex.org/T14364 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9901000261306763 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Clusterin in disease pathology |
| topics[2].id | https://openalex.org/T14245 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9832000136375427 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | Biomarkers in Disease Mechanisms |
| is_xpac | False |
| apc_list.value | 2950 |
| apc_list.currency | USD |
| apc_list.value_usd | 2950 |
| apc_paid.value | 2950 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2950 |
| concepts[0].id | https://openalex.org/C2781197716 |
| concepts[0].level | 2 |
| concepts[0].score | 0.6478776335716248 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q864574 |
| concepts[0].display_name | Biomarker |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.6294788122177124 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C121608353 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5288699269294739 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[2].display_name | Cancer |
| concepts[3].id | https://openalex.org/C2781230642 |
| concepts[3].level | 3 |
| concepts[3].score | 0.42289677262306213 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q492646 |
| concepts[3].display_name | Targeted therapy |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.25628700852394104 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C86803240 |
| concepts[5].level | 0 |
| concepts[5].score | 0.16251614689826965 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[5].display_name | Biology |
| concepts[6].id | https://openalex.org/C55493867 |
| concepts[6].level | 1 |
| concepts[6].score | 0.0 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[6].display_name | Biochemistry |
| keywords[0].id | https://openalex.org/keywords/biomarker |
| keywords[0].score | 0.6478776335716248 |
| keywords[0].display_name | Biomarker |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.6294788122177124 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/cancer |
| keywords[2].score | 0.5288699269294739 |
| keywords[2].display_name | Cancer |
| keywords[3].id | https://openalex.org/keywords/targeted-therapy |
| keywords[3].score | 0.42289677262306213 |
| keywords[3].display_name | Targeted therapy |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.25628700852394104 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/biology |
| keywords[5].score | 0.16251614689826965 |
| keywords[5].display_name | Biology |
| language | en |
| locations[0].id | doi:10.3389/fimmu.2025.1625734 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2595292759 |
| locations[0].source.issn | 1664-3224 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1664-3224 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Frontiers in Immunology |
| locations[0].source.host_organization | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_name | Frontiers Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320527 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1625734/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Frontiers in Immunology |
| locations[0].landing_page_url | https://doi.org/10.3389/fimmu.2025.1625734 |
| locations[1].id | pmid:40977743 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Frontiers in immunology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40977743 |
| locations[2].id | pmh:oai:europepmc.org:11253425 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12443790 |
| locations[3].id | pmh:oai:doaj.org/article:91252cdf069743c6a1172cc7a94325f8 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Frontiers in Immunology, Vol 16 (2025) |
| locations[3].landing_page_url | https://doaj.org/article/91252cdf069743c6a1172cc7a94325f8 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5115596389 |
| authorships[0].author.orcid | https://orcid.org/0009-0006-7421-1451 |
| authorships[0].author.display_name | Qian Wang |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210131893 |
| authorships[0].affiliations[0].raw_affiliation_string | The Precision Medical Institute, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China |
| authorships[0].institutions[0].id | https://openalex.org/I4210131893 |
| authorships[0].institutions[0].ror | https://ror.org/03aq7kf18 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210131893 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | Second Affiliated Hospital of Xi'an Jiaotong University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Qian Wang |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | The Precision Medical Institute, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China |
| authorships[1].author.id | https://openalex.org/A5101256505 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Yu Yan |
| authorships[1].countries | CN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I199305430, https://openalex.org/I4210122818, https://openalex.org/I83519826 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Pathology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China |
| authorships[1].institutions[0].id | https://openalex.org/I83519826 |
| authorships[1].institutions[0].ror | https://ror.org/059gcgy73 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I83519826 |
| authorships[1].institutions[0].country_code | CN |
| authorships[1].institutions[0].display_name | Nanjing Medical University |
| authorships[1].institutions[1].id | https://openalex.org/I199305430 |
| authorships[1].institutions[1].ror | https://ror.org/02afcvw97 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I199305430 |
| authorships[1].institutions[1].country_code | CN |
| authorships[1].institutions[1].display_name | Nantong University |
| authorships[1].institutions[2].id | https://openalex.org/I4210122818 |
| authorships[1].institutions[2].ror | https://ror.org/02fvevm64 |
| authorships[1].institutions[2].type | healthcare |
| authorships[1].institutions[2].lineage | https://openalex.org/I4210122818 |
| authorships[1].institutions[2].country_code | CN |
| authorships[1].institutions[2].display_name | Taizhou People's Hospital |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Yan Yu |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Pathology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China |
| authorships[2].author.id | https://openalex.org/A5077190393 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-0312-7149 |
| authorships[2].author.display_name | Liang Xiao |
| authorships[2].countries | CN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210131893 |
| authorships[2].affiliations[0].raw_affiliation_string | National‐Local Joint Engineering Research Center of Biodiagnosis & Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China |
| authorships[2].institutions[0].id | https://openalex.org/I4210131893 |
| authorships[2].institutions[0].ror | https://ror.org/03aq7kf18 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210131893 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | Second Affiliated Hospital of Xi'an Jiaotong University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Xiao Liang |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | National‐Local Joint Engineering Research Center of Biodiagnosis & Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China |
| authorships[3].author.id | https://openalex.org/A5042511913 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-7474-6855 |
| authorships[3].author.display_name | Dan Wan |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210131893 |
| authorships[3].affiliations[0].raw_affiliation_string | National‐Local Joint Engineering Research Center of Biodiagnosis & Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China |
| authorships[3].institutions[0].id | https://openalex.org/I4210131893 |
| authorships[3].institutions[0].ror | https://ror.org/03aq7kf18 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210131893 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Second Affiliated Hospital of Xi'an Jiaotong University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Dan Wan |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | National‐Local Joint Engineering Research Center of Biodiagnosis & Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China |
| authorships[4].author.id | https://openalex.org/A5102016496 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-8043-6562 |
| authorships[4].author.display_name | Ke Du |
| authorships[4].countries | CN |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210131893 |
| authorships[4].affiliations[0].raw_affiliation_string | National‐Local Joint Engineering Research Center of Biodiagnosis & Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China |
| authorships[4].institutions[0].id | https://openalex.org/I4210131893 |
| authorships[4].institutions[0].ror | https://ror.org/03aq7kf18 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210131893 |
| authorships[4].institutions[0].country_code | CN |
| authorships[4].institutions[0].display_name | Second Affiliated Hospital of Xi'an Jiaotong University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Ke Du |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | National‐Local Joint Engineering Research Center of Biodiagnosis & Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China |
| authorships[5].author.id | https://openalex.org/A5043847800 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-2583-5437 |
| authorships[5].author.display_name | Pengpeng Zhu |
| authorships[5].countries | CN |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210131893 |
| authorships[5].affiliations[0].raw_affiliation_string | National‐Local Joint Engineering Research Center of Biodiagnosis & Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China |
| authorships[5].institutions[0].id | https://openalex.org/I4210131893 |
| authorships[5].institutions[0].ror | https://ror.org/03aq7kf18 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210131893 |
| authorships[5].institutions[0].country_code | CN |
| authorships[5].institutions[0].display_name | Second Affiliated Hospital of Xi'an Jiaotong University |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Pengpeng Zhu |
| authorships[5].is_corresponding | True |
| authorships[5].raw_affiliation_strings | National‐Local Joint Engineering Research Center of Biodiagnosis & Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1625734/pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Pan-cancer analysis of PIEZO1: a promising biomarker for diagnosis, prognosis, and targeted therapies |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12286 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9995999932289124 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2737 |
| primary_topic.subfield.display_name | Physiology |
| primary_topic.display_name | Erythrocyte Function and Pathophysiology |
| related_works | https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725 |
| cited_by_count | 0 |
| locations_count | 4 |
| best_oa_location.id | doi:10.3389/fimmu.2025.1625734 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2595292759 |
| best_oa_location.source.issn | 1664-3224 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1664-3224 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Frontiers in Immunology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_name | Frontiers Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1625734/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Frontiers in Immunology |
| best_oa_location.landing_page_url | https://doi.org/10.3389/fimmu.2025.1625734 |
| primary_location.id | doi:10.3389/fimmu.2025.1625734 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2595292759 |
| primary_location.source.issn | 1664-3224 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1664-3224 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Frontiers in Immunology |
| primary_location.source.host_organization | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_name | Frontiers Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1625734/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Frontiers in Immunology |
| primary_location.landing_page_url | https://doi.org/10.3389/fimmu.2025.1625734 |
| publication_date | 2025-09-04 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4393935425, https://openalex.org/W4387931183, https://openalex.org/W4306734898, https://openalex.org/W4392965448, https://openalex.org/W4291516836, https://openalex.org/W2912743928, https://openalex.org/W3133562023, https://openalex.org/W3088497047, https://openalex.org/W4298326482, https://openalex.org/W2896032894, https://openalex.org/W4302024164, https://openalex.org/W2956663107, https://openalex.org/W4290729340, https://openalex.org/W4380264648, https://openalex.org/W3101920301, https://openalex.org/W4399879655, https://openalex.org/W2012034410, https://openalex.org/W2533508881, https://openalex.org/W2114843025, https://openalex.org/W2896872272, https://openalex.org/W2972917142, https://openalex.org/W2900569176, https://openalex.org/W3027286012, https://openalex.org/W2804658429, https://openalex.org/W4290072634, https://openalex.org/W3130270219, https://openalex.org/W4408732920, https://openalex.org/W2886498337, https://openalex.org/W2617493931, https://openalex.org/W3130578067, https://openalex.org/W3203777534, https://openalex.org/W2948388080, https://openalex.org/W3201370547, https://openalex.org/W3005714439, https://openalex.org/W3009206285, https://openalex.org/W2012045650, https://openalex.org/W4206011150, https://openalex.org/W4200088478, https://openalex.org/W3043516311, https://openalex.org/W4402252614, https://openalex.org/W4385955972, https://openalex.org/W4387388526, https://openalex.org/W2000647244, https://openalex.org/W3044473529, https://openalex.org/W4396706922, https://openalex.org/W4322768225, https://openalex.org/W4283319696, https://openalex.org/W4388870000, https://openalex.org/W4388903731, https://openalex.org/W2982130750, https://openalex.org/W3004999692, https://openalex.org/W4405229804, https://openalex.org/W4317481671, https://openalex.org/W3081516066 |
| referenced_works_count | 54 |
| abstract_inverted_index.. | 257 |
| abstract_inverted_index./ | 254 |
| abstract_inverted_index.1 | 5 |
| abstract_inverted_index.R | 106, 132 |
| abstract_inverted_index.a | 7, 20, 265 |
| abstract_inverted_index.4% | 209 |
| abstract_inverted_index.as | 19, 63, 69 |
| abstract_inverted_index.in | 13, 23, 148, 159, 170, 204, 208, 223, 246, 252, 255 |
| abstract_inverted_index.is | 264 |
| abstract_inverted_index.of | 210, 274 |
| abstract_inverted_index.on | 162, 173 |
| abstract_inverted_index.or | 119 |
| abstract_inverted_index.to | 43, 144 |
| abstract_inverted_index.Cox | 76 |
| abstract_inverted_index.Our | 177, 259 |
| abstract_inverted_index.PCR | 136 |
| abstract_inverted_index.The | 37, 108 |
| abstract_inverted_index.and | 65, 78, 89, 112, 138, 153, 184, 200, 228, 238, 248, 272 |
| abstract_inverted_index.for | 268 |
| abstract_inverted_index.has | 16, 182 |
| abstract_inverted_index.ion | 229 |
| abstract_inverted_index.its | 27, 169, 249 |
| abstract_inverted_index.the | 97, 105, 131, 269 |
| abstract_inverted_index.via | 96 |
| abstract_inverted_index.was | 50, 73, 194 |
| abstract_inverted_index.(WB) | 141 |
| abstract_inverted_index.LIHC | 247 |
| abstract_inverted_index.This | 34 |
| abstract_inverted_index.been | 17 |
| abstract_inverted_index.cell | 226 |
| abstract_inverted_index.data | 42 |
| abstract_inverted_index.role | 30, 251 |
| abstract_inverted_index.some | 24 |
| abstract_inverted_index.that | 180, 217, 262 |
| abstract_inverted_index.used | 36 |
| abstract_inverted_index.vivo | 171, 256 |
| abstract_inverted_index.were | 84, 94, 102, 128, 142, 206, 220 |
| abstract_inverted_index.with | 59, 196, 234 |
| abstract_inverted_index.(ROC) | 56 |
| abstract_inverted_index.Atlas | 40 |
| abstract_inverted_index.LAG3, | 125 |
| abstract_inverted_index.cases | 64 |
| abstract_inverted_index.curve | 57 |
| abstract_inverted_index.found | 207 |
| abstract_inverted_index.gated | 9 |
| abstract_inverted_index.genes | 219 |
| abstract_inverted_index.grade | 199 |
| abstract_inverted_index.study | 35 |
| abstract_inverted_index.tests | 88 |
| abstract_inverted_index.tumor | 61, 113, 174, 198, 235 |
| abstract_inverted_index.using | 52, 86, 104, 130 |
| abstract_inverted_index.value | 49, 72, 186 |
| abstract_inverted_index.vitro | 160, 253 |
| abstract_inverted_index.while | 165 |
| abstract_inverted_index.wound | 154 |
| abstract_inverted_index.(TCGA) | 41 |
| abstract_inverted_index.CTLA4, | 124 |
| abstract_inverted_index.Cancer | 38 |
| abstract_inverted_index.Colony | 151 |
| abstract_inverted_index.Genome | 39 |
| abstract_inverted_index.PDCD1, | 126 |
| abstract_inverted_index.PIEZO1 | 45, 111, 146, 181, 192, 205, 231, 244, 263 |
| abstract_inverted_index.across | 187 |
| abstract_inverted_index.assays | 156 |
| abstract_inverted_index.cancer | 163, 189 |
| abstract_inverted_index.cation | 10 |
| abstract_inverted_index.cells, | 164 |
| abstract_inverted_index.immune | 120, 239 |
| abstract_inverted_index.impact | 172 |
| abstract_inverted_index.marker | 267 |
| abstract_inverted_index.models | 167 |
| abstract_inverted_index.normal | 67 |
| abstract_inverted_index.scores | 115, 237 |
| abstract_inverted_index.stage. | 201 |
| abstract_inverted_index.types. | 190 |
| abstract_inverted_index.(CD274, | 123 |
| abstract_inverted_index.Genomic | 92, 202 |
| abstract_inverted_index.Immune, | 117 |
| abstract_inverted_index.Methods | 33 |
| abstract_inverted_index.Results | 176 |
| abstract_inverted_index.Western | 139 |
| abstract_inverted_index.analyze | 44 |
| abstract_inverted_index.between | 110 |
| abstract_inverted_index.calcium | 14 |
| abstract_inverted_index.channel | 3, 11 |
| abstract_inverted_index.effects | 161 |
| abstract_inverted_index.growth. | 175 |
| abstract_inverted_index.healing | 155 |
| abstract_inverted_index.markers | 122 |
| abstract_inverted_index.primary | 60 |
| abstract_inverted_index.remains | 31 |
| abstract_inverted_index.samples | 62 |
| abstract_inverted_index.through | 75 |
| abstract_inverted_index.tissues | 68 |
| abstract_inverted_index.Blotting | 140 |
| abstract_inverted_index.Clinical | 82 |
| abstract_inverted_index.Elevated | 191 |
| abstract_inverted_index.However, | 26 |
| abstract_inverted_index.Receiver | 53 |
| abstract_inverted_index.adjacent | 66 |
| abstract_inverted_index.advanced | 197 |
| abstract_inverted_index.analyses | 215 |
| abstract_inverted_index.analysis | 178 |
| abstract_inverted_index.analyzed | 103, 129 |
| abstract_inverted_index.assessed | 157 |
| abstract_inverted_index.cancers. | 25 |
| abstract_inverted_index.clinical | 149 |
| abstract_inverted_index.detected | 85 |
| abstract_inverted_index.enriched | 222 |
| abstract_inverted_index.findings | 260 |
| abstract_inverted_index.indicate | 261 |
| abstract_inverted_index.involved | 12 |
| abstract_inverted_index.logistic | 90 |
| abstract_inverted_index.oncogene | 22 |
| abstract_inverted_index.pathways | 101 |
| abstract_inverted_index.quantify | 145 |
| abstract_inverted_index.revealed | 179, 216 |
| abstract_inverted_index.survival | 80 |
| abstract_inverted_index.targeted | 275 |
| abstract_inverted_index.(PIEZO1), | 6 |
| abstract_inverted_index.(Stromal, | 116 |
| abstract_inverted_index.(qRT-PCR) | 137 |
| abstract_inverted_index.ESTIMATE) | 118 |
| abstract_inverted_index.Operating | 54 |
| abstract_inverted_index.PDCD1LG2) | 127 |
| abstract_inverted_index.Real-Time | 135 |
| abstract_inverted_index.analyses. | 81 |
| abstract_inverted_index.analysis, | 58 |
| abstract_inverted_index.component | 4 |
| abstract_inverted_index.confirmed | 243 |
| abstract_inverted_index.controls. | 70 |
| abstract_inverted_index.database. | 99 |
| abstract_inverted_index.different | 188 |
| abstract_inverted_index.evaluated | 51, 168 |
| abstract_inverted_index.formation | 152 |
| abstract_inverted_index.language. | 107, 133 |
| abstract_inverted_index.patients. | 212 |
| abstract_inverted_index.performed | 143 |
| abstract_inverted_index.potential | 21 |
| abstract_inverted_index.profiles. | 47 |
| abstract_inverted_index.promising | 266 |
| abstract_inverted_index.xenograft | 166 |
| abstract_inverted_index.Conclusion | 258 |
| abstract_inverted_index.Diagnostic | 48 |
| abstract_inverted_index.Functional | 100, 213 |
| abstract_inverted_index.PIEZO1’s | 158 |
| abstract_inverted_index.Piezo-type | 1 |
| abstract_inverted_index.Prognostic | 71 |
| abstract_inverted_index.associated | 195 |
| abstract_inverted_index.cBioPortal | 98 |
| abstract_inverted_index.checkpoint | 121 |
| abstract_inverted_index.correlated | 233 |
| abstract_inverted_index.determined | 74 |
| abstract_inverted_index.diagnosis, | 270 |
| abstract_inverted_index.diagnostic | 183 |
| abstract_inverted_index.enrichment | 214 |
| abstract_inverted_index.expression | 46, 147, 193 |
| abstract_inverted_index.identified | 95 |
| abstract_inverted_index.migration, | 227 |
| abstract_inverted_index.pan-cancer | 29, 211, 276 |
| abstract_inverted_index.positively | 232 |
| abstract_inverted_index.prognosis, | 271 |
| abstract_inverted_index.prognostic | 185 |
| abstract_inverted_index.recognized | 18 |
| abstract_inverted_index.regression | 77 |
| abstract_inverted_index.signaling, | 15, 225 |
| abstract_inverted_index.specimens. | 150 |
| abstract_inverted_index.therapies. | 277 |
| abstract_inverted_index.validation | 242 |
| abstract_inverted_index.alterations | 93, 203 |
| abstract_inverted_index.association | 109 |
| abstract_inverted_index.development | 273 |
| abstract_inverted_index.regression. | 91 |
| abstract_inverted_index.unexplored. | 32 |
| abstract_inverted_index.ECM-receptor | 224 |
| abstract_inverted_index.Experimental | 241 |
| abstract_inverted_index.Introduction | 0 |
| abstract_inverted_index.Kaplan-Meier | 79 |
| abstract_inverted_index.Quantitative | 134 |
| abstract_inverted_index.checkpoints. | 240 |
| abstract_inverted_index.correlations | 83 |
| abstract_inverted_index.homeostasis. | 230 |
| abstract_inverted_index.mechanically | 8 |
| abstract_inverted_index.comprehensive | 28 |
| abstract_inverted_index.significantly | 221 |
| abstract_inverted_index.Characteristic | 55 |
| abstract_inverted_index.non-parametric | 87 |
| abstract_inverted_index.overexpression | 245 |
| abstract_inverted_index.pro-tumorigenic | 250 |
| abstract_inverted_index.mechanosensitive | 2 |
| abstract_inverted_index.microenvironment | 114, 236 |
| abstract_inverted_index.PIEZO1-coexpressed | 218 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5043847800 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 6 |
| corresponding_institution_ids | https://openalex.org/I4210131893 |
| citation_normalized_percentile.value | 0.49860095 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |